Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by goldn1on Oct 03, 2019 10:28pm

143 Views

Post# 30194787

RE:RE:RE:RE:RE:Theralase Corp Investor Conference Oct 25th

typically, the reason companies have these special meetings is because they are going to announce something which they feel is big enough to have a presentation/Q&A for institutional and retail investors. TLT has not always done things in a way I would do, but if they are just going bring ppl in only to have the same presentation they did at the AGM, it would be a waste of time, money and make the company look worse in everyone's eyes. Shareholder sentiment isn't great now, so I expect a number of big announcements from now until the date of the meeting... just my opinion... G1

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price